insights_auto
Outlook: 37.5% bullish·15.6% bearish
Go to analysischevron_right
ARGX:NASDAQ
argenx SE - ADR
၈၂၅.၀၃ US$
arrow_upward
+၀.၇၈%(+၆.၄၀) 1D
အောက် ၉, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
၈၂၁.၉၆ US$
High
၈၂၆.၇၈ US$
Low
၈၀၅.၀၇ US$
Mkt. cap
ဋေ ၅.၀၁ ထ
Avg. vol.
၃.၃၃ သိန်း
Volume
၀.၀၀
P/E ratio
၃၁.၃၄
52-wk high
၁,၀၇၂.၇၅ US$
52-wk low
၆၆၁.၈၅ US$
EPS
၂၆.၃၂ US$
Beta
၀.၄၅
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
Open
၈၂၁.၉၆ US$
High
၈၂၆.၇၈ US$
Low
၈၀၅.၀၇ US$
Mkt. cap
ဋေ ၅.၀၁ ထ
Avg. vol.
၃.၃၃ သိန်း
Volume
၀.၀၀
P/E ratio
၃၁.၃၄
52-wk high
၁,၀၇၂.၇၅ US$
52-wk low
၆၆၁.၈၅ US$
EPS
၂၆.၃၂ US$
Beta
၀.၄၅
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ နာရီ
argenx stock pre-market at EUR 734.10
Stock Traders Daily
·
ပြီးခဲ့သည့် ၁ ရက်
Price-Driven Insight from (ARGX) for Rule-Based Strategy
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Argenx stock sits at EUR 736.30 after a week of mixed trial news
WSJ
·
ပြီးခဲ့သည့် ၃ ရက်
Argenx Shares Plunge After Autoimmune-Disease Trial Halt
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR